HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Formulas For Success: Abbott Touts Similarity To Breast Milk, ByHeart Promotes ‘Clean Label’

Executive Summary

Infant nutrition giant Abbott extends its Similac line with its “closest formula to breast milk ever” while startup ByHeart approaches its initial launch with announcement its formula is first certified by  Clean Label Project.

You may also be interested in...



US FDA ‘Closer To Zero’ Meeting On Infant Nutrition Safety And Benefits Set For November

CFSAN launched “C2Z” initiative in April following widespread reports of contamination of baby food products. Agency officials will outline C2Z plan including a four-stage approach for continual improvement and additional work related to levels of toxic elements in food.

Second Atlanta-Area Business Faces Criminal Charges Linked To Steroid-Spiked Supplements

CCB Nutrition owner pleads guilty in federal court to selling an unapproved new drug with the intent to defraud and mislead the FDA and consumers. Hi-Tech Pharmaceuticals CEO still faces criminal charges after Supreme Court refused his appeal after trial and appellate court rejected motion to dismiss an indictment alleging he distributed steroid-spiked supplements and falsified compliance documents.

C&D Expands Oral Care Portfolio, Acquires TheraBreath Mouthwash Brand In Latest Deal

Church & Dwight anticipates 15% growth for TheraBreath mouthwash brand in 2022 on larger sizes and wider distribution, especially outside US. It plans to acquire the firm for around $580m cash and close the deal before end of year

Topics

UsernamePublicRestriction

Register

RS151960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel